Related Experiment Videos
Acute liver failure induced by carbamazepine
N Hadzić1, B Portmann, E T Davies
1King's College School of Medicine and Dentistry, London Department of Immunology.
Archives of Disease in Childhood
|March 1, 1990
Summary
Carbamazepine can cause acute liver failure in children, likely due to an immunoallergic reaction. Early monitoring of liver function and signs of idiosyncrasy may prevent this severe complication.
Area of Science:
- Pediatric Hepatology
- Clinical Pharmacology
Background:
- Carbamazepine is a widely used antiepileptic drug.
- Drug-induced liver injury (DILI) is a rare but serious adverse effect.
Observation:
- Two pediatric cases of acute liver failure associated with carbamazepine use were observed.
- Clinical and laboratory findings suggested an immunoallergic mechanism.
Findings:
- One child showed improvement with corticosteroid treatment, indicating an immune-mediated component.
- The reaction appears to be idiosyncratic, meaning it is unpredictable and not dose-dependent.
Implications:
- Close monitoring of liver function is crucial during the initial weeks of carbamazepine therapy.
- Early recognition of idiosyncratic reactions to carbamazepine can aid in timely intervention.
- This highlights the importance of pharmacovigilance for antiepileptic drugs in pediatric populations.